Neocortical atrophy in Machado-Joseph disease: A longitudinal neuroimaging study

Journal of Neuroimaging

Volumn 22, Issue 3, 2012, Pages 285-291

  D'Abreu, Anelyssa ^a   França, Marcondes C ^a   Yasuda, Clarissa L ^a   Campos, Bruno A G ^a   Lopes Cendes, Iscia ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cortical atrophy; Machado Joseph disease; Spectroscopy; Spinocerebellar ataxia type 3; Voxel based morphometry

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; AGING; ARTICLE; ATAXIA; BRAIN CORTEX ATROPHY; BRAIN STEM; CAG REPEAT; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FEMALE; FOLLOW UP; FRONTAL LOBE; GRAY MATTER; HUMAN; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MACHADO JOSEPH DISEASE; MALE; NEOCORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; ONSET AGE; OUTCOME ASSESSMENT; PARIETAL LOBE; RATING SCALE; STUDENT T TEST; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACHADO-JOSEPH DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOCORTEX; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84863777746     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2011.00614.x     Document Type: Article

References (41)

1. Takiyama Y, Nishizawa M, Tananka H, et al. The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet 1993;4:300-304.
2. Nakano KK, Dawson DM, Spence A. Machado disease: a hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology 1972;22:49-55.
3. Romanul FC, Fowler HL, Radvany J, et al. Azorean disease of the nervous system. N Engl J Med 1977;296:1505-1508.
4. Rosenberg RN, Nyhan WL, Bay C, et al. Autosomal dominant striato-nigral degeneration: a clinical, pathologic and biochemical study of a new genetic disorder. Neurology 1976;26:703-714.
5. Woods BT, Schaumburg HH. Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia: a unique and partially treatable clinico-pathological entity. J Neurol Sci 1972;17:149-166.
6. Teive HA, Iwamoto FM, Camargo CH, et al. Machado-Joseph disease versus hereditary spastic paraplegia: case report. Arq Neuropsiquiatr 2001;59:809-811.
7. Rosenberg RN. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov Disord 1992;7:193-203.
8. D'Abreu A, Friedman J, Coskun J. Non-movement disorder heralds symptoms of Machado-Joseph disease years before ataxia. Mov Disord 2005;20:739-741.
9. Fukutake T, Shinotoh H, Nishino H, et al. Homozygous Machado-Joseph disease presenting as REM sleep behaviour disorder and prominent psychiatric symptoms. Eur J Neurol 2002;9:97-100.
10. Løkkegaard T, Nielsen JE, Hasholt L, et al. Machado-Joseph disease in three Scandinavian families. J Neurol Sci 1998;156:152-715.
11. Pinto S, de Carvalho M. Machado-Joseph disease presenting as motor neuron disease. Amyotroph Lateral Scler 2007;9:188-191.
12. Lima L, Coutinho P. Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family. Neurology 1980;30:319-322.
13. Dürr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996;39:490-499.
14. Tokumaru AM, Kamakura K, Maki T, et al. Magnetic resonance imaging findings of Machado-Joseph disease: histopathologic correlation. J Comput Assist Tomogr 2003;27:241-248.
15. Rüb U, Gierga K, Brunt ER, et al. Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm 2005;112:1523-1545.
16. Yamada S, Nishimiya J, Nakajima T, et al. Linear high intensity area along the medial margin of the internal segment of the globus pallidus in Machado-Joseph disease patients. J Neurol Neurosurg Psychiatry 2005;76:573-575.
17. Abe Y, Tanaka F, Matsumoto M, et al. CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease. Neurology 1998;51:882-884.
18. Yoshizawa T, Watanabe M, Frusho K, et al. Magnetic resonance imaging demonstrates differential atrophy of pontine base and tegmentum in Machado-Joseph disease. J Neurol Sci 2003;215:45-50.
19. D'Abreu A, França MC Jr, Yasuda CL, et al. Thalamic volume and dystonia in Machado-Joseph Disease. J Neuroimaging 2011 Apr;21(2):e91-93; DOI:
20. Rüb U, Brunt ER, Deller T. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease). Curr Opin Neurol 2008;21:111-116.
21. Murata Y, Kawakami H, Yamaguchi S, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 1998;55:33-37.
22. Etchebehere EC, Cendes F, Lopes-Cendes I, et al. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol 2001;58:1257-1263.
23. Taniwaki T, Sakai T, Kobayashi T, et al. Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci 1997;145(1):63-67.
24. D'Abreu A, França M Jr, Appenzeller S, et al. Axonal dysfunction in the deep white matter in Machado-Joseph Disease. J Neuroimaging 2009;19(1):9-12.
25. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
26. Trouillas P, Takayanagi T, Hallett M, et al. International cooperative ataxia rating scale for pharmachological assessment of the cerebellar syndrome. J Neurol Sci 1997;145:205-211.
27. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labelling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single subject brain. NeuroImage 2002;15:273-289.
28. Collins DL, Zijdenbos AP, Kollokian V, et al. Design and construction of a realistic digital brain phantom. IEEE Trans Medical Imaging 1998;17:463-468.
29. Lukas C, Schöls L, Bellenberg B, et al. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study. Neurosci Lett 2006;408:230-235.
30. Schulz JB, Borkert J, Wolf S, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 2010;49(1):158-168.
31. Coutinho P, Guimarães A, Scaravilli F. The pathology of Machado-Joseph disease. Report of a possible homozygous case. Acta Neuropathol 1982;58(1):48-54.
32. Paulson HL, Das SS, Crino PB, et al. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 1997;41:453-462.
33. Ishikawa A, Yamada M, Makino K, et al. Dementia and delirium in 4 patients with Machado-Joseph disease. Arch Neurol 2002;59:1804-1808.
34. Kawai Y, Takeda A, Abe Y, et al. Cognitive impairments in Machado-Joseph disease. Arch Neurol 2004;61(11):1757-1760.
35. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998;121:561-579.
36. Horimoto Y, Matsumoto M, Yuasa H, et al. Brainstem in Machado-Joseph disease: atrophy or small size? Eur J Neurol 2008;15:102-105.
37. Klockgether T, Schöls L, Abele M, et al. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD). J Neurol Neurosurg Psychiatry 1999;66:222-224.
38. Schmitz-Hübsch T, Tezenas du Montcel S, et al. Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 Spinocerebellar Ataxia Patients. Mov Disord 2006;21:699-704.
39. D'Abreu A, Franca M Jr, Lopes-Cendes I, et al. The international cooperative ataxia rating scale in Machado-Joseph disease. Comparison with the unified multiple system atrophy rating scale. Mov Disord 2007;22:1976-1979.
40. Schmitz-Hübsch T, du Montcel ST, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66(11):1717-1720.
41. Ruocco HH, Bonilha L, Li LM, et al. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 2008;79:130-135.